| Literature DB >> 24076605 |
Wendy McKelvey1, J Bryan Jacobson, Daniel Kass, Dana Boyd Barr, Mark Davis, Antonia M Calafat, Kenneth M Aldous.
Abstract
BACKGROUND: Organophosphates and pyrethroids are the most common classes of insecticides used in the United States. Widespread use of these compounds to control building infestations in New York City (NYC) may have caused higher exposure than in less-urban settings.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24076605 PMCID: PMC3855501 DOI: 10.1289/ehp.1206015
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Population-weighted percentiles of uncorrected and creatinine-corrected urinary concentrations of dialkyl phosphates in the NYC HANES 2004 study population.
| Metabolite | Percent detects | 50th percentile (95% CI) | 95th percentile (95% CI) | |||
|---|---|---|---|---|---|---|
| Uncorrected (μg/L) | Creatinine corrected (μg/g) | Uncorrected (μg/L) | Creatinine corrected (μg/g) | |||
| DMP (dimethylphosphate) | 881 | 47.1 | < LOD | < LOD | 87.40 (67.00, 103.00) | 88.65 (66.16, 105.00) |
| DMTP (dimethylthiophosphate) | 881 | 44.4 | < LOD | < LOD | 74.70 (41.90, 121.00) | 45.78 (28.20, 73.24) |
| DMDTP (dimethyldithiophosphate) | 883 | 27.9 | < LOD | < LOD | 17.10 (8.13, 27.30) | 8.73 (7.07, 18.21) |
| DEP (diethylphosphate) | 883 | 57.0 | 0.79 (0.28, 1.31) | 0.52 (0.35, 0.78) | 11.90 (10.80, 14.30) | 11.78 (8.55, 14.31) |
| DETP (diethylthiophosphate) | 880 | 18.5 | < LOD | < LOD | 3.28 (2.17, 4.08) | 1.89 (1.31, 2.69) |
| DEDTP (diethyldithiophosphate) | 883 | 5.6 | < LOD | < LOD | 0.10 (< LOD, 1.53) | 0.54 (0.31, 1.20) |
Population-weighted percentiles of uncorrected and creatinine-corrected urinary ∑DAP, ∑DMAP, and ∑DEAP concentrations in the NYC HANES 2004 study population.
| Analytes/characteristic | 50th percentile (95% CI) | 95th percentile (95% CI) | |||
|---|---|---|---|---|---|
| Uncorrected (nmol/L) | Creatinine corrected (nmol/g) | Uncorrected (nmol/L) | Creatinine corrected (nmol/g) | ||
| ∑DAP | |||||
| All | 876 | 114.92 (93.77, 141.53) | 83.09 (66.53, 101.36) | 1321.8 (870.18, 1739.1) | 1003.9 (867.34, 1411.3) |
| Sex | |||||
| Male | 345 | 122.04 (91.81, 184.47) | 81.21 (48.78, 123.43) | 1496.4 (897.03, 1665.3) | 1003.7 (857.54, 1532.5) |
| Female | 531 | 108.14 (86.29, 130.50) | 85.04 (68.03, 101.52) | 1180.2 (743.40, 2245.1) | 1049.0 (774.35, 1622.9) |
| Age (years) | |||||
| 20–39 | 434 | 91.13 (70.31, 118.45) | 57.43 (44.45, 81.21) | 1044.0 (720.09, 1601.7) | 918.67 (585.87, 1069.2) |
| 40–59 | 331 | 108.94 (81.96, 144.93) | 91.67 (60.19, 123.43) | 1321.8 (808.58, 1665.3) | 1265.6 (826.06, 1839.9) |
| ≥ 60 | 111 | 192.50 (115.42, 342.43) | 170.42 (79.25, 266.95) | 1496.4 (640.05, 3534.5) | 910.18 (703.45, 1781.4) |
| Race/ethnicity | |||||
| White, non-Hispanic | 239 | 135.26 (93.54, 190.02) | 121.85 (76.72, 171.45) | 1942.3 (865.06, 3534.5) | 1532.5 (1003.9, 2207.2) |
| Black, non-Hispanic | 186 | 114.92 (82.86, 174.68) | 77.86 (44.91, 98.73) | 967.28 (777.27, 1407.7) | 897.37 (472.21, 1370.1) |
| Asian, non-Hispanic | 116 | 69.79 (42.37, 123.12) | 61.93 (31.60, 137.04) | 626.53 (350.94, 868.10) | 995.91 (398.00, 2657.4) |
| Hispanic | 318 | 102.77 (73.99, 140.96) | 74.65 (50.41, 91.70) | 803.61 (674.82, 1439.0) | 850.59 (467.63, 1024.8) |
| ∑DMAP | |||||
| All | 879 | 83.54 (65.70, 110.44) | 57.82 (40.77, 75.34) | 1134.8 (825.06, 1542.3) | 992.59 (855.55, 1334.2) |
| Sex | |||||
| Male | 347 | 110.23 (69.65, 140.69) | 61.54 (38.89, 103.39) | 1346.7 (859.01, 1542.3) | 992.59 (836.71, 1516.1) |
| Female | 532 | 76.40 (52.42, 95.79) | 55.07 (39.73, 72.98) | 1082.0 (687.94, 2113.8) | 982.60 (700.78, 1554.3) |
| Age (years) | |||||
| 20–39 | 435 | 62.11 (51.56, 78.59) | 38.52 (26.67, 55.35) | 898.65 (657.89, 1542.3) | 883.54 (512.43, 1040.6) |
| 40–59 | 333 | 86.54 (57.76, 128.78) | 62.05 (38.22, 90.25) | 1225.1 (789.89, 1542.3) | 1169.3 (707.00, 1746.7) |
| ≥ 60 | 111 | 172.96 (92.05, 315.28) | 153.25 (61.03, 235.41) | 1494.7 (605.47, 3478.0) | 870.89 (700.78, 1779.4) |
| Race/ethnicity | |||||
| White, non-Hispanic | 240 | 101.95 (62.11, 159.98) | 94.33 (42.04, 145.83) | 1855.3 (868.01, 3478.0) | 1287.6 (921.01, 2194.6) |
| Black, non-Hispanic | 187 | 86.91 (54.69, 140.69) | 52.64 (28.39, 83.67) | 880.07 (712.11, 1494.7) | 855.55 (503.10, 1389.3) |
| Asian, non-Hispanic | 117 | 53.94 (21.74, 98.62) | 33.12 (21.00, 92.84) | 603.55 (349.22, 843.86) | 885.40 (392.12, 2614.3) |
| Hispanic | 318 | 80.04 (58.15, 110.23) | 48.82 (34.89, 71.60) | 771.64 (635.92, 1320.1) | 828.69 (403.53, 1024.1) |
| ∑DEAP | |||||
| All | 880 | 9.61 (7.77, 12.53) | 6.41 (5.03, 8.18) | 97.19 (83.26, 108.83) | 90.00 (73.57, 120.90) |
| Sex | |||||
| Male | 347 | 5.10 (1.71, 9.56) | 3.88 (2.84, 5.33) | 84.62 (69.97, 113.09) | 58.17 (36.64, 141.66) |
| Female | 533 | 13.13 (9.69, 17.03) | 10.21 (7.50, 12.10) | 102.74 (84.71, 117.72) | 102.83 (83.94, 130.86) |
| Age (years) | |||||
| 20–39 | 435 | 11.77 (8.62, 14.69) | 6.51 (4.95, 8.34) | 93.82 (74.48, 119.38) | 76.29 (54.27, 112.83) |
| 40–59 | 333 | 9.43 (5.10, 14.63) | 7.35 (5.03, 10.53) | 102.74 (76.32, 119.63) | 116.43 (65.57, 165.52) |
| ≥ 60 | 112 | 7.77 (1.71, 13.13) | 3.94 (2.91, 9.64) | 96.47 (43.39, 126.77) | 92.34 (39.27, 166.36) |
| Race/ethnicity | |||||
| White, non-Hispanic | 242 | 8.95 (5.15, 13.13) | 6.73 (4.26, 10.48) | 104.04 (74.13, 154.69) | 130.02 (65.26, 179.91) |
| Black, non-Hispanic | 186 | 15.65 (9.61, 21.90) | 8.86 (4.85, 12.95) | 96.47 (74.82, 119.38) | 55.97 (42.76, 71.33) |
| Asian, non-Hispanic | 116 | 3.87 (1.71, 10.47) | 4.19 (2.39, 7.41) | 74.82 (50.64, 131.72) | 120.90 (58.85, 199.14) |
| Hispanic | 319 | 9.04 (4.61, 11.84) | 5.33 (3.39, 6.84) | 82.34 (65.59, 106.71) | 84.69 (50.89, 112.83) |
Adjusted LSGMs for urinary ∑DAP concentrations across study population characteristics, NYC HANES 2004.
| Characteristic | Crude GM (nmol/L) (95% CI) | LSGM (nmol/L) (95% CI) | ||
|---|---|---|---|---|
| Sex | ||||
| Male | 329 | 113 (92, 138) | 109 (90, 132) | |
| Female | 519 | 92 (76, 112) | 95 (80, 113) | 0.24 |
| Age (years) | ||||
| 20–39 | 417 | 86 (72, 103) | 89 (75, 107) | |
| 40–59 | 325 | 98 (79, 122) | 98 (79, 121) | |
| ≥ 60 | 106 | 147 (99, 217) | 136 (97, 192) | 0.03 |
| Race/ethnicity | ||||
| White, non-Hispanic | 238 | 119 (91, 157) | 116 (90, 149) | 0.03 |
| Black, non-Hispanic | 183 | 110 (84, 144) | 111 (85, 144) | 0.18 |
| Asian, non-Hispanic | 114 | 73 (55, 97) | 80 (60, 108) | 0.69 |
| Hispanic | 313 | 85 (69, 104) | 84 (69, 103) | Reference |
| Professional pest control | ||||
| Yes | 238 | 121 (91, 161) | 124 (96, 160) | |
| No | 610 | 94 (80, 111) | 94 (81, 109) | 0.08 |
| Weekly fruit servings | ||||
| 0–2 | 238 | 79 (63, 99) | 74 (59, 94) | |
| 3–6 | 202 | 93 (69, 126) | 91 (68, 122) | |
| 7 | 283 | 116 (91, 147) | 118 (94, 149) | |
| > 7 | 125 | 127 (89, 183) | 141 (102, 195) | < 0.01 |
| Weekly servings of non-green vegetables | ||||
| 0–2 | 205 | 96 (76, 122) | 107 (84, 136) | |
| 3–6 | 285 | 119 (97, 145) | 126 (103, 153) | |
| 7 | 266 | 101 (80, 128) | 97 (78, 122) | |
| > 7 | 92 | 70 (40, 123) | 55 (32, 92) | 0.02 |
Population-weighted percentiles of uncorrected and creatinine-corrected urinary concentrations of pyrethroid metabolites in the NYC HANES 2004 study population.
| Metabolite | Percent detects | 50th percentile (95% CI) | 95th percentile (95% CI) | |||
|---|---|---|---|---|---|---|
| Uncorrected (μg/L) | Creatinine corrected (μg/g) | Uncorrected (μg/L) | Creatinine corrected (μg/g) | |||
| 4-F-3PBA (4-fluoro-3-phenoxybenzoic acid) | 1,452 | 8.1 | < LOD | < LOD | 0.44 (0.37, 0.52) | 1.13 (1.00, 1.34) |
| 1,311 | 1.5 | < LOD | < LOD | < LOD | < LOD | |
| 1,452 | 14.0 | < LOD | < LOD | 5.94 (4.44, 8.17) | 6.66 (5.51, 8.29) | |
| 3-PBA (3-phenoxybenzoic acid) | 1,452 | 58.5 | 0.76 (0.72, 0.81) | 0.75 (0.69, 0.82) | 5.23 (4.29, 6.26) | 4.51 (3.89, 5.80) |
Population-weighted percentiles of uncorrected and creatinine-corrected urinary 3‑PBA concentrations in the NYC HANES 2004 study population.
| Characteristic | 50th percentile (95% CI) | 95th percentile (95% CI) | |||
|---|---|---|---|---|---|
| Uncorrected (μg/L) | Creatinine corrected (μg/g) | Uncorrected (μg/L) | Creatinine corrected (μg/g) | ||
| All | 1,452 | 0.76 (0.72, 0.81) | 0.75 (0.69, 0.82) | 5.23 (4.29, 6.26) | 4.51 (3.89, 5.80) |
| Sex | |||||
| Male | 602 | 0.76 (0.70, 0.82) | 0.61 (0.55, 0.68) | 4.70 (3.66, 6.34) | 3.30 (2.94, 4.00) |
| Female | 850 | 0.76 (0.71, 0.82) | 0.89 (0.82, 0.99) | 5.65 (4.33, 7.83) | 6.00 (4.24, 8.81) |
| Age (years) | |||||
| 20–39 | 708 | 0.78 (0.72, 0.84) | 0.69 (0.62, 0.79) | 5.42 (4.05, 8.22) | 4.08 (3.27, 5.22) |
| 40–59 | 554 | 0.75 (0.69, 0.81) | 0.83 (0.71, 0.89) | 5.31 (3.71, 6.79) | 4.59 (3.91, 7.42) |
| ≥ 60 | 190 | 0.78 (0.45, 0.92) | 0.76 (0.63, 1.00) | 4.36 (2.56, 7.73) | 4.97 (3.15, 16.58) |
| Race/ethnicity | |||||
| White, non-Hispanic | 411 | 0.76 (0.65, 0.85) | 0.83 (0.76, 0.94) | 5.26 (3.66, 10.23) | 6.00 (4.23, 13.78) |
| Black, non-Hispanic | 315 | 0.87 (0.79, 0.95) | 0.63 (0.55, 0.69) | 5.50 (3.22, 9.41) | 3.18 (2.66, 4.19) |
| Asian, non-Hispanic | 180 | 0.88 (0.71, 1.02) | 1.12 (0.98, 1.47) | 6.26 (4.41, 10.89) | 7.89 (4.45, 15.57) |
| Hispanic | 519 | 0.67 (0.45, 0.73) | 0.63 (0.56, 0.71) | 4.05 (3.08, 5.42) | 3.46 (2.57, 5.11) |
Adjusted LSGMs for urinary 3‑PBA concentrations across study population characteristics, NYC HANES 2004.
| Characteristic | Crude GM (μg/L) (95% CI) | LSGM (μg/L) (95% CI) | ||
|---|---|---|---|---|
| Sex | ||||
| Male | 578 | 0.92 (0.86, 0.99) | 0.87 (0.81, 0.93) | |
| Female | 826 | 0.93 (0.87, 1.01) | 0.98 (0.91, 1.06) | 0.02 |
| Age (years) | ||||
| 20–39 | 683 | 0.95 (0.87, 1.02) | 0.92 (0.85, 0.99) | |
| 40–59 | 538 | 0.92 (0.86, 0.99) | 0.94 (0.88, 1.01) | |
| ≥ 60 | 183 | 0.90 (0.78, 1.04) | 0.92 (0.80, 1.06) | 0.88 |
| Race/ethnicity | ||||
| White, non-Hispanic | 408 | 0.93 (0.84, 1.03) | 0.95 (0.85, 1.05) | 0.05 |
| Black, non-Hispanic | 308 | 0.99 (0.89, 1.11) | 0.91 (0.82, 1.01) | 0.21 |
| Asian, non-Hispanic | 176 | 1.08 (0.92, 1.26) | 1.15 (0.99, 1.35) | < 0.01 |
| Hispanic | 512 | 0.82 (0.75, 0.90) | 0.84 (0.76, 0.92) | Reference |
| Professional pest control | ||||
| Yes | 407 | 0.99 (0.89, 1.09) | 0.98 (0.9, 1.08) | |
| No | 997 | 0.91 (0.85, 0.97) | 0.91 (0.86, 0.96) | 0.15 |
| Weekly green vegetable servings | ||||
| 0–2 | 443 | 0.81 (0.75, 0.88) | 0.83 (0.77, 0.90) | |
| 3–6 | 459 | 0.98 (0.89, 1.07) | 0.97 (0.89, 1.05) | |
| 7 | 345 | 0.91 (0.83, 0.99) | 0.91 (0.84, 1.00) | |
| > 7 | 157 | 1.16 (0.94, 1.44) | 1.12 (0.91, 1.36) | 0.01 |
| Education | ||||
| < High school | 417 | 0.88 (0.80, 0.96) | 0.89 (0.81, 0.99) | |
| High school graduate | 260 | 0.91 (0.79, 1.05) | 0.89 (0.77, 1.02) | |
| Some college | 303 | 0.85 (0.78, 0.93) | 0.85 (0.78, 0.92) | |
| ≥ College degree | 424 | 1.04 (0.94, 1.14) | 1.03 (0.93, 1.15) | 0.11 |
Figure 1Comparison of 95th percentiles and 95% CIs for urinary organophosphate metabolite concentrations in adults 20–59 years of age in NYC (NYC HANES 2004; present study) and nationwide (NHANES 2003–2004; CDC 2013b).
Figure 2Comparison of 95th percentiles and 95% CIs for urinary pyrethroid metabolite concentrations in adults 20–59 years of age in NYC (NYC HANES 2004; present study) and nationwide [NHANES 2001–2002 (most recent year available for estimates of urinary pyrethroid metabolite concentrations); CDC 2009]. The absence of a bar indicates a 95th percentile < LOD.